Kyntra Bio, Inc. (KYNB) Tops Q2 EPS by 614c

Kyntra Bio, Inc. (NASDAQ: KYNB) reported Q2 EPS of $2.96, $6.14 better than the analyst estimate of ($3.18).

For earnings history and earnings-related data on Kyntra Bio, Inc. (KYNB) click here.

You May Also Be Interested In

• UBS Reiterates Buy Rating on Dutch Bros Inc. (BROS): 'One of Strongest Growth Stories in Restaurants'
• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS